Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Christiane P. Tiefenbacher"'
Autor:
John G. Webb, Stefan James, Karl Heinz Kuck, Jan Harnek, Gregg W. Stone, Christopher E. Buller, Christiane P. Tiefenbacher, Carsten Tschöpe, Alec Vahanian
Publikováno v:
JACC: Cardiovascular Interventions. 4(1):115-122
Objectives This study sought to assess the safety and efficacy of transcatheter valve annuloplasty in patients with mitral regurgitation (MR). Background Mitral regurgitation is associated with a worsened prognosis in patients with dilated cardiomyop
Autor:
Christiane P. Tiefenbacher, Hans C. Volz, Alexandra Zankl, Erwin Blessing, Hugo A. Katus, Ulrike Krumsdorf, Boris Ivandic, Martin Andrassy
Publikováno v:
Clinical Research in Cardiology. 99:787-794
Peripheral artery disease (PAD) is associated with high cardiovascular mortality and a poor quality of life. The AT1-receptor blocker telmisartan has been shown to have pleiotropic effects and it may also improve endothelial function. The aim of this
Autor:
Jia Shen, Thomas Braun, Hugo A. Katus, Frank Plöger, Christiane P. Tiefenbacher, Zhipei Liu, Xiaobo Chen, Kui Pu
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1793:1819-1827
GDF5 and BMP2, members of the TGF-β superfamily of growth factors, are known to regulate apoptosis in different cell types either positively or negatively. We wanted to investigate the effects of GDF5 and BMP2 on vascular smooth muscle cells and mou
Autor:
Hugo A. Katus, Alexandra Zankl, Ulrike Krumsdorf, Christiane P. Tiefenbacher, Robin Joyce Barrows
Publikováno v:
Angiology. 60:462-467
Background. Peripheral arterial disease (PAD) indicates generalized atherosclerosis but is still underdiagnosed and undertreated. Methods. Data were collected from patients with PAD from the Department of Cardiology and Angiology, University of Heide
Publikováno v:
Heart. 90:1189-1193
To disclose possible influences of alcoholic beverages on restenosis rate in men with coronary artery disease treated with percutaneous transluminal coronary angioplasty (PTCA) and stent implantation.Retrospective cohort study.225 consecutive male pa
Autor:
Jolanthe Kapitza, Christiane P. Tiefenbacher, Lars P. Kihm, Johannes Törnig, Martin Zeier, Kerstin Amann, Ralf Dikow, Eberhard Ritz
Publikováno v:
Journal of the American Society of Nephrology. 15:1530-1536
In patients with renal failure, myocardial infarction (MI) is more frequent and the rate of death from acute MI is very high. It has been argued that ischemia tolerance of the heart is reduced in uremia, but direct evidence for this hypothesis has no
Autor:
Xiaobo Chen, Tina Bleeke, Christiane P. Tiefenbacher, Stefanie Friedrich, Feraydoon Niroomand, Christian F. Vahl
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 286:H1425-H1432
Long-term treatment with angiotensin-converting enzyme (ACE) inhibitors as well as angiotensin II type 1 (AT1) receptor antagonists and statins reduces cardiovascular mortality in patients with coronary artery disease as well as chronic heart failure
Publikováno v:
British Journal of Pharmacology. 140:1019-1026
1. Receptor-independent activation of heterotrimeric G proteins by plasma membrane-associated nucleoside diphosphate kinase (NDPK) has been demonstrated in vivo, and elevated levels of NDPK were found in purified sarcolemmal membranes of patients wit
Autor:
Jolanthe Kapitza, Christiane P. Tiefenbacher, Ching-Hua Lee, Feraydoon Niroomand, Volker Dietz
Publikováno v:
Pfl�gers Archiv European Journal of Physiology. 447:1-7
A reduced availability of tetrahydrobiopterin (BH4), an essential cofactor for NO-synthesis, is causally involved in the development of endothelial dysfunction associated with ischemia/reperfusion. We, therefore, investigated the effect of sepiapteri
Autor:
Ruediger Becker, M Meyborg, Christiane P. Tiefenbacher, Feraydoon Niroomand, Roman Mura, Jochen Michaelsen
Publikováno v:
Heart. 89:629-632
Objective: To investigate the prognostic value of induced monomorphic ventricular tachycardia (VT) and ventricular flutter or fibrillation (VF) during programmed electrical stimulation in patients with a high risk for sudden arrhythmogenic cardiac de